Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic scientific tests, and ensures security in exploration, enhancing reproducibility and advancing growing older and oncology investigations. everyday laboratory workflows normally expose gaps where by current compounds fail to address mobile senescence